Citius Oncology, Inc. (CTOR)
1.12
-0.01
(-0.88%)
USD |
NASDAQ |
Dec 12, 16:00
1.12
0.00 (0.00%)
After-Hours: 16:09
Citius Oncology Cash from Operations (Quarterly): 0.00 for June 30, 2025
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -5.407M |
| Amicus Therapeutics, Inc. | 35.66M |
| Soligenix, Inc. | -2.933M |
| Tonix Pharmaceuticals Holding Corp. | -30.47M |
| GT Biopharma, Inc. | -3.677M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -0.3641M |
| Free Cash Flow to Firm (Quarterly) | 0.1691M |
| Free Cash Flow Yield | -0.45% |